Drreddys Laboratories | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Canopy Growth CAD 591.48M 81.81M 2024-12
Cipla INR 284.56B 0 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Drreddys Laboratories INR 317.72B 12.38B 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Hikma Pharmaceutical USD 2.29B 88M 2024-06
Lonza CHF 9.33B 23M 2024-12
Novartis USD 44.05B 605M 2024-12
Pacira USD 778.35M 28.76M 2024-12
Prestige Brands USD 1.79B 56.67M 2024-12
Richter Gedeon HUF 1.3T 76.1B 2024-12
Sun Pharmaceuticals INR 693.8B 22.74B 2024-09
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Teva Pharmaceutical Industries USD 5.72B 344M 2024-12



Drreddys Laboratories Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.